Fouzia Laghrissi-Thode, MD, joined AZ in her current role in 2013.
Fouzia has spent almost 20 years in the pharmaceutical industry at Roche, Novartis and Sandoz in a wide range of areas including product strategy, clinical development, strategic and global marketing and business development and licensing. She has worked across therapy areas including central nervous system and genito-urinary.
Immediately prior to joining AZ, Fouzia was Head of Global Product Strategy for Cardiometabolism and Anaemia at Roche. She led the franchise leadership team responsible for Bonviva, NeoRecormon, Mircera and the overall cardiometabolism portfolio.
As well as her doctorate in medicine, Fouzia holds a certificate in pharmaceutical medicine. She is a board-certified psychiatrist and is Adjunct Professor of Psychiatry at the University of Pittsburgh in the US.